Alan E Smith's Net Worth

$27.7 Million

Estimate Recalculated Mar 20, 2025 03:36PM EST

Who is Alan E Smith?

Alan E Smith has an estimated net worth of $27.7 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, and Candel Therapeutics, Inc..

SEC CIK

Alan E Smith's CIK is 0001021037

Past Insider Trading and Trends

2003 was Alan E Smith's most active year for acquiring shares with 26 total transactions. Alan E Smith's most active month to acquire stocks was the month of May. 2003 was Alan E Smith's most active year for disposing of shares, totalling 36 transactions. Alan E Smith's most active month to dispose stocks was the month of May. 2008 saw Alan E Smith paying a total of $3,428,679.58 for 185,980 shares, this is the most they've acquired in one year. In 2008 Alan E Smith cashed out on 252,619 shares for a total of $10,452,096.07, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GENZYME CORP No price found

Sr VP,Chief Scientific Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-37.84K
$74.00
-$3,378,618.00
0
Apr 4
Form 4
—
0
—
—
0
Jun 16
Form 4
-4.46%
-1.74K
$49.54
-$86,050.98
37.21K
May 27
Form 4
+8.62%
5.99K
$45.63
-$218,510.10
75.42K
May 22 - May 25
Form 4
+2.67%
1.74K
$48.93
-$40,220.46
66.74K
May 21
Form 4
—
0
$41.57
-$486,548.38
31.06K
Mar 4
Form 4
-5.55%
-1.81K
$61.40
-$111,064.82
30.78K
Jun 2
Form 4
+5.88%
1.81K
$56.54
-$50,036.31
32.59K
May 22 - May 26
Form 4
—
0
—
—
0
May 21
Form 4
—
0
$47.31
-$1,983,765.33
30.5K
Dec 8
Form 4
—
0
$57.52
-$749,850.00
30.5K
Aug 14
Form 4
—
0
$53.72
-$1,348,074.16
30.5K
Aug 5
Form 4/A
—
0
$79.70
-$1,470,863.50
30.5K
Scheduled
Jul 15
Form 4
—
0
$79.70
-$1,470,863.50
30.5K
Scheduled
Jul 15
Form 4
-2.23%
-690.00
—
—
30.22K
Mar 28 - May 22
Form 4
—
0
$52.22
-$911,200.00
30.78K
Dec 17
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 25
Form 4
—
0
$47.79
-$1,685,461.07
29.86K
Nov 16
Form 4
—
0
$52.94
-$940,000.00
29.86K
Nov 11
Form 4
—
0
$50.95
-$860,200.00
29.85K
Sep 12
Form 4
—
0
$41.73
-$1,217,011.68
29.85K
Jul 19
Form 4
—
0
$45.93
-$767,607.54
29.67K
Jun 16
Form 4
—
0
—
—
0
May 26
Form 4
-5.18%
-1.61K
$40.14
-$761,520.34
29.51K
Jan 14 - Jan 27
Form 4
—
0
$34.89
-$644,657.18
30.94K
Nov 22
Form 4
—
0
$34.81
-$1,324,265.16
30.94K
Nov 12
Form 4
—
0
$33.66
-$483,170.61
30.89K
Aug 19
Form 4/A
—
0
$32.82
-$1,317,088.74
30.89K
Jul 20
Form 4
—
0
$32.82
-$1,317,088.74
30.89K
Jul 20
Form 4
—
0
—
—
0
May 27
Form 4/A
-4.30%
-2.63K
—
—
58.47K
Jun 30
Form 4/A
-3.32%
-2.00K
$27.00
-$392,700.00
58.33K
Jun 12
Form 4
—
0
$29.37
-$759,082.80
58.8K
Sep 15
Form 4
-11.98%
-8.00K
$48.33
-$386,640.00
58.8K
Sep 11
Form 4
+13.40%
7.89K
$25.34
$199,972.50
66.8K
Sep 3
Form 4
-0.17%
-100.00
$28.18
-$499,680.00
58.91K
Sep 2 - Sep 3
Form 4
—
0
$27.19
-$475,800.00
59K
Aug 21
Form 4
—
0
$26.44
-$383,400.00
59K
Scheduled
Aug 13
Form 4
—
0
$25.69
-$552,600.00
59K
Scheduled
Aug 6
Form 4
—
0
$28.91
-$865,600.00
59K
Scheduled
Jul 30
Form 4
—
0
—
—
0
Scheduled
Form 4
—
0
—
—
0
Scheduled
Form 4
—
0
—
—
0
Scheduled
Form 4
—
0
—
—
0
Scheduled
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
No matching records found

Candel Therapeutics, Inc. (CADL) Snapshot price: $6.31

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found